Shiva Fekri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shiva Fekri has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Masoud Hassanzadeh Makoui
Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
4 shared publications - N. El Ansari
Department of Internal Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
4 shared publications - Fazel Shokri
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Loabat Geranpayeh
Department of Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Mohammad Mehdi Amiri
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 8 August 2025
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 33 (158) , 209-217
Hypertension, Lifestyle Factors, and Breast Cancer Outcomes: A Decade-Long Retrospective Cohort Study
Background & Objective: Breast cancer is the second leading cause of cancer-related mortality in women and is influenced by genetic, environmental, and lifestyle factors. This study aimed to evaluate the prevalence of risk factors in breast cancer patients and their association with disease progression and survival. Materials & Methods: A retrospective ...
- 8 August 2025
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 33 (158) , 209-217
Open AccessHypertension, Lifestyle Factors, and Breast Cancer Outcomes: A Decade-Long Retrospective Cohort Study
Background & Objective: Breast cancer is the second leading cause of cancer-related mortality in women and is influenced by genetic, environmental, and lifestyle factors. This study aimed to evaluate the prevalence of risk factors in breast cancer patients and their association with disease progression and survival. Materials & Methods: A retrospective ...
- Open Access
- 10 June 2024
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 21 (2) , 104-117
Correlation between the existence of serum autoantibodies and the risk of endometriosis: A systematic review and meta-analysis
Correlation between the existence of serum autoantibodies and the risk of endometriosis: A systematic review and meta-analysis - Turkish Journal of Obstetrics and Gynecology
- 10 June 2024
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 21 (2) , 104-117
Open AccessCorrelation between the existence of serum autoantibodies and the risk of endometriosis: A systematic review and meta-analysis
Correlation between the existence of serum autoantibodies and the risk of endometriosis: A systematic review and meta-analysis - Turkish Journal of Obstetrics and Gynecology
- Open Access
- 10 June 2024
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 21 (2) , 118-122
Effects of bazedoxifene on endometriosis in experimental animal models: A systematic review and meta-analysis
Effects of bazedoxifene on endometriosis in experimental animal models: A systematic review and meta-analysis - Turkish Journal of Obstetrics and Gynecology
- 10 June 2024
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 21 (2) , 118-122
Open AccessEffects of bazedoxifene on endometriosis in experimental animal models: A systematic review and meta-analysis
Effects of bazedoxifene on endometriosis in experimental animal models: A systematic review and meta-analysis - Turkish Journal of Obstetrics and Gynecology
- Open Access
- 8 December 2023
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 20 (4) , 314-319
Individual effects of GSTM1 and GSTT1 polymorphisms on the risk of polycystic ovarian syndrome: A systematic review and meta-analysis
This study aimed to understand the relationship between two specific genetic variations (GSTT1 and GSTM1 polymorphisms) and the risk of developing polycystic ovarian syndrome (PCOS). PCOS is a common endocrinologic disorder that affects women. Oxidative stress may play a significant role in the development of PCOS. Certain enzymes, such as glutathione S-transferases, help protect cells against oxidative stress. However, previous research on the correlation between these specific genetic variations and PCOS risk has produced inconsistent findings. To address this, a meta-analysis was conducted to examine the potential impact of these genetic variations on PCOS. We conducted a thorough search of the Embase, PubMed, Scopus, Web of Science, and Google Scholar databases to find studies that met our criteria. We used fixed-effects or random-effects models to determine the pooled odds ratios (ORs) and 95% confidence intervals (CIs) of the GSTT1 and GSTM1 polymorphisms related to PCOS. We also performed subgroup analyses based on ethnicity, mean age of participants, and PCOS diagnostic protocols. After screening, we found five studies with 1.607 participants (872 in the PCOS group and 735 in the control group) to be suitable for our meta-analysis. Our analysis showed that GSTM1 and GSTT1 null genotypes were not linked to an increased risk of PCOS (OR: 0.925, 95% CI: 0.755-1.134; OR: 1.175, 95% CI: 0.614-2.247 respectively). Additionally, both Begg's and Egger's tests revealed no publishing bias. This meta-analysis confirmed that there is no association between GSTM1 and GSTT1 polymorphisms and an increased risk of PCOS. However, further studies are required to validate this conclusion.
- 8 December 2023
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 20 (4) , 314-319
Open AccessIndividual effects of GSTM1 and GSTT1 polymorphisms on the risk of polycystic ovarian syndrome: A systematic review and meta-analysis
This study aimed to understand the relationship between two specific genetic variations (GSTT1 and GSTM1 polymorphisms) and the risk of developing polycystic ovarian syndrome (PCOS). PCOS is a common endocrinologic disorder that affects women. Oxidative stress may play a significant role in the development of PCOS. Certain enzymes, such as glutathione S-transferases, help protect cells against oxidative stress. However, previous research on the correlation between these specific genetic variations and PCOS risk has produced inconsistent findings. To address this, a meta-analysis was conducted to examine the potential impact of these genetic variations on PCOS. We conducted a thorough search of the Embase, PubMed, Scopus, Web of Science, and Google Scholar databases to find studies that met our criteria. We used fixed-effects or random-effects models to determine the pooled odds ratios (ORs) and 95% confidence intervals (CIs) of the GSTT1 and GSTM1 polymorphisms related to PCOS. We also performed subgroup analyses based on ethnicity, mean age of participants, and PCOS diagnostic protocols. After screening, we found five studies with 1.607 participants (872 in the PCOS group and 735 in the control group) to be suitable for our meta-analysis. Our analysis showed that GSTM1 and GSTT1 null genotypes were not linked to an increased risk of PCOS (OR: 0.925, 95% CI: 0.755-1.134; OR: 1.175, 95% CI: 0.614-2.247 respectively). Additionally, both Begg's and Egger's tests revealed no publishing bias. This meta-analysis confirmed that there is no association between GSTM1 and GSTT1 polymorphisms and an increased risk of PCOS. However, further studies are required to validate this conclusion.